Washington University in St. Louis
St Louis, United States
Publications on this disease179
Research view
Switch to patient viewHeart failure: who works on it
Groups that published on this disease or run trials on it, from public registries and publications. Researchers appear by name only once their profile is published.
Find fellow researchers
One card per institution. Pick a target or a country to narrow the list.
- All targets
- SGLT2 29
- GLP-1 6
- TTR 10
- AMPK 0
- NLRP3 0
- NRF2 0
- PI3K 0
- PPAR 0
- AKT 0
- mTOR 0
- HER2 2
- STAT3 0
- TP53 0
- MAPK 0
- SIRT1 0
- STING 0
- EGFR 0
- GIP 4
- HIF-1 0
- PCSK9 0
- DPP-4 0
- VEGF 0
- HMGB1 0
- IL-6 0
- TNF 0
- CTNNB1 0
- YAP 0
- PINK1 0
- ERK 0
- GPX4 0
- JAK 0
- TLR4 0
- IL-1 0
- JNK 0
- MEK 1
- HSP90 0
- DMD 0
- IL-17 0
- MMP-9 0
- PD-1 0
- CD40 0
- COX-2 0
- HDAC 0
- PD-L1 0
- TFEB 0
- ABL1 0
- APOE 0
- AR 0
- BCL-2 0
- FTO 0
- METTL3 0
- MYC 0
- PTEN 0
- ACE2 0
- BDNF 0
- BRAF 0
- BRD4 0
- BTK 0
- CDK4/6 0
- FAK 0
1 of 1+ institutions, ordered by recent publications and open trials. This is not a ranking of quality.
Running research funding
Funded research projects that name this disease in their title, terms or summary and have not ended yet: who is funded, where, how much and until when. Organisations only; the funder's page has the details.
NIH NINR · F31
NIH NINR · R01
NIH NINR · R01
NIH NINR · K99
Leveraging Nurses to Improve Care for Postural Orthostatic Tachycardia Syndrome
NIH NINR · R01
The Roles, Contributions, and Patient Outcomes Associated with Registered Nurses in Primary Care
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
Integrative Modeling of Autonomic dysfunction and Cardiac arrhyThmogenesis (IMpACT)
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-ERC
Bioinspired Modulation of Cardiac Troponin I Splicing to Treat Diastolic Dysfunction (TROPOSplice)
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-ERC
From n=1 to many: Scaling-up gene editing for future heart therapies (ONE2MANY)
The disease is named only in the funder's project summary, not in the title.
European Commission (Horizon Europe) · HORIZON-TMA-MSCA-PF-EF
European Commission (Horizon Europe) · HORIZON-CSA
10 of 1,993 running projects, newest first. Listed amounts together: US$1.1bn + €318.2m.
Sources: NIH RePORTER (U.S. National Institutes of Health, public domain) and CORDIS (European Commission, CC BY 4.0). Changes: filtered by disease, organisations matched to ROR.
Who stopped a trial, and why
Terminated, withdrawn and suspended trials with the reason the sponsor gave in the registry, quoted word for word.
Terminated
HER2HEART-US: Prevention of Cardiotoxicity in Breast Cancer Patients Receiving HER2-directed Therapy
“Futility”Registry text, quoted unchanged. Source
Trials that share participant data
Trials whose registry record says individual participant data (IPD) will be shared.
Search by method
Find publications on this disease by a MeSH method term, for example a sequencing or imaging method.
- Single-Cell Analysis 17
- Organoids 5
- Mendelian Randomization Analysis 79
- CRISPR-Cas Systems 7
- Gene Expression Profiling 71
- Sequence Analysis, RNA 1
- Whole Genome Sequencing 2
- Exome Sequencing 10
- Proteomics 108
- Metabolomics 64
- Mass Spectrometry 5
- Flow Cytometry 10
- Immunohistochemistry 13
- Xenograft Model Antitumor Assays 2
- Positron-Emission Tomography 37
- Magnetic Resonance Imaging 155
- Machine Learning 199
- Deep Learning 42
- Cohort Studies 503
- Genome-Wide Association Study 74
Paste an abstract
See which targets of this disease your abstract mentions, and go to the people working on them.
Matched in your browser only. The text is not sent, saved or logged.
Sources: ClinicalTrials.gov, EU CTR, OpenAlex, PubMed, NIH RePORTER, CORDIS. Machine-matched links are labelled.